BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6978665)

  • 1. Effects of drugs and antibodies on the post-synaptic membrane of the neuromuscular junction.
    Peper K; Sterz R; Bradley RJ
    Ann N Y Acad Sci; 1981; 377():519-43. PubMed ID: 6978665
    [No Abstract]   [Full Text] [Related]  

  • 2. The neuromuscular junction: recent developments.
    Bowman WC
    Eur J Anaesthesiol; 1985 Mar; 2(1):59-93. PubMed ID: 2410263
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates.
    Hohlfeld R; Sterz R; Kalies I; Wekerle H; Peper K
    Muscle Nerve; 1983 Feb; 6(2):160-3. PubMed ID: 6304508
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro blockade of neuromuscular transmission by monoclonal anti-acetylcholine receptor antibodies.
    Maselli RA; Jow B; Richman DP; Nelson DJ
    Ann N Y Acad Sci; 1988; 540():523-4. PubMed ID: 2849901
    [No Abstract]   [Full Text] [Related]  

  • 5. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
    Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of dose-response curves by quantitative ionophoresis at the frog neuromuscular junction.
    Dreyer F; Peper K; Sterz R
    J Physiol; 1978 Aug; 281():395-419. PubMed ID: 309003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion of acetylcholine in the synaptic cleft of normal and myasthenia gravis human endplates.
    Cull-Candy SG; Miledi R; Uchitel OD
    Nature; 1980 Jul; 286(5772):500-2. PubMed ID: 7402330
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of myasthenic immunoglobulins and of prednisolone on spontaneous miniature end-plate potentials in mouse diaphragms.
    Dudel J; Birnberger KL; Toyka KV; Schlegel C; Besinger U
    Exp Neurol; 1979 Nov; 66(2):365-80. PubMed ID: 226390
    [No Abstract]   [Full Text] [Related]  

  • 9. Properties of end-plate channels in rats immunized against acetylcholine receptors.
    Alemà S; Cull-Candy SG; Miledi R; Trautmann A
    J Physiol; 1981 Feb; 311():251-66. PubMed ID: 6267252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis.
    Ito Y; Miledi R; Vincent A; Newsom-Davis J
    Brain; 1978 Jun; 101(2):345-68. PubMed ID: 667602
    [No Abstract]   [Full Text] [Related]  

  • 11. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis.
    Engel AG
    Prog Brain Res; 1979; 49():423-34. PubMed ID: 515440
    [No Abstract]   [Full Text] [Related]  

  • 12. Endplate blocking actions of lophotoxin.
    Atchison WD; Narahashi T; Vogel SM
    Br J Pharmacol; 1984 Jul; 82(3):667-72. PubMed ID: 6146369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do peripheral nerves contain a factor inducing acetylcholine sensitivity in skeletal muscle?
    Vyskocil F; Syrový I
    Experientia; 1979 Feb; 35(2):218-9. PubMed ID: 421836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors.
    Lennon VA; Lambert EH
    Nature; 1980 May; 285(5762):238-40. PubMed ID: 6154894
    [No Abstract]   [Full Text] [Related]  

  • 15. Voltage dependence of agonist effectiveness at the frog neuromuscular junction: resolution of a paradox.
    Dionne VE; Stevens CF
    J Physiol; 1975 Oct; 251(2):245-70. PubMed ID: 1081139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How myasthenia gravis alters the safety factor for neuromuscular transmission.
    Ruff RL; Lennon VA
    J Neuroimmunol; 2008 Sep; 201-202():13-20. PubMed ID: 18632162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-receptor interaction at the frog neuromuscular junction.
    Dreyer F; Peper K; Sterz R; Bradley RJ; Müller KD
    Prog Brain Res; 1979; 49():213-23. PubMed ID: 42113
    [No Abstract]   [Full Text] [Related]  

  • 18. Duchenne dystrophy: ultrastructural localization of the acetylcholine receptor and intracellular microelectrode studies of neuromuscular transmission.
    Sakakibara H; Engel AG; Lambert EH
    Neurology; 1977 Aug; 27(8):741-5. PubMed ID: 196235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of forskolin on the response of acetylcholine receptors in frog sartorius endplate.
    Deana A; Scuka M
    Neurosci Lett; 1990 Jul; 114(3):272-6. PubMed ID: 1698269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization at the frog neuromuscular junction: a biphasic process.
    Feltz A; Trautmann A
    J Physiol; 1982 Jan; 322():257-72. PubMed ID: 6978400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.